首页 | 本学科首页   官方微博 | 高级检索  
     


Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia,Irrespective of Low-Density Lipoprotein Receptor Defects
Authors:Gilles Lambert  Francine Petrides  Mathias Chatelais  Dirk J. Blom  Benjamin Choque  Fatiha Tabet  Gida Wong  Kerry-Anne Rye  Amanda J. Hooper  John R. Burnett  Philip J. Barter  A. David Marais
Affiliation: Faculté de Médecine, Université de Nantes, UMR PhAN 1280, Nantes, France; Lipid Research Group, Heart Research Institute, Sydney, Australia; Centre for Vascular Research, University of New South Wales, Sydney, Australia;§ Lipidology Division of Internal Medicine, MRC Cape Heart Group, University of Cape Town Health Science Faculty, Cape Town, South Africa; Royal Perth Hospital, Department of Clinical Biochemistry, PathWest Laboratory of Medicine WA, Perth, Australia; School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia;# School of Medicine and Pharmacology, University of Western Australia, Perth, Australia;∗∗ Chemical Pathology Division of Clinical Laboratory Sciences, MRC Cape Heart Group, University of Cape Town Health Science Faculty, Cape Town, South Africa
Abstract:
Keywords:familial hypercholesterolemia   LDL-cholesterol   LDL   receptor   PCSK9
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号